尽管已陷入内卷狂潮,但HER2仍然是当下最热门靶点之一,也是众多药企攻克的核心靶点。曲妥珠单抗,是*个以HER2为靶点的靶向药...
12/12 13:51
11/20 10:30
09/25 11:02
09/24 22:07
09/24 22:02
09/05 22:53
08/22 11:46
08/22 10:54
08/18 14:02
08/04 19:25